TKI258 for Metastatic Inflammatory Breast Cancer Patients

Condition:   Breast CancerIntervention:   Drug: DovitinibSponsors:   M.D. Anderson Cancer Center;   NovartisActive, not recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials